Funding
$5.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops biomedicine using mesenchymal stem cells derived from umbilical cord tissue to treat septic shock. This approach aims to enhance intensive care management for patients suffering from this complex syndrome.